I might be missing something but I don't understand why there needs to be a combination of Sarepta's drug with ours.
Their drug did no better than placebo whilst ours reduced inflammation and stabilised or reduced fat.
Why charge the victims of this disease for two drugs when only one seems to be helping.
Research note, page-88
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.015(15.0%) |
Mkt cap ! $103.6M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.0¢ | $255.1K | 2.302M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1035536 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 646310 | 7 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |